Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GUCY1B3 |
| Upstream (Parents) |
|---|
| (<<) PXDN → GUCY1B3 |
| (<<) LHFP → GUCY1B3 |
| (<<) GUCY1A3 → GUCY1B3 |
| Downstream (Children) |
|---|
| GUCY1B3 → GGT5 (>>) |
| GUCY1B3 → C10orf72 (>>) |
| GUCY1B3 → MAP3K12 (>>) |
| GUCY1B3 → ASPN (>>) |
| GUCY1B3 → FGF1 (>>) |
| GUCY1B3 → ADAMTS1 (>>) |
| GUCY1B3 → GUCY1A3 (>>) |
| GUCY1B3 → TMEM47 (>>) |
| GUCY1B3 → AKAP5 (>>) |
| GUCY1B3 → ADAMTS2 (>>) |
| GUCY1B3 → CRIP2 (>>) |
| GUCY1B3 → ITGA4 (>>) |
| GUCY1B3 → F2R (>>) |
| GUCY1B3 → SYNPO (>>) |
| GUCY1B3 → CD93 (>>) |
